Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Pharmaceutical Policy and Practice
The first of its kind in Cyprus, this study underscores a prevailing lack of public knowledge regarding paracetamol, including misunderstandings about its composition and concerning practices such as combining it with alcohol.
Clinical Pharmacology July 31st 2023
Journal of the American Pharmacists Association (JAPhA)
The SAGE-AF study provides valuable insights into the cost-reducing behaviors among older adults with atrial fibrillation, highlighting the need for targeted interventions, especially for those with cognitive impairments. Explore the study to understand how these behaviors are shaping medication management in this vulnerable population.
Cardiology July 31st 2023
Pharmacy Today
The recent ban on gender-affirming care for minors in Texas underscores the urgent need for pharmacists to act as knowledgeable allies and advocates for transgender patients. Your role in education, advocacy, and trust-building is now more crucial than ever; learn more about how you can help.
The New England Journal of Medicine
The recent phase 3 trial on pitavastatin’s effectiveness in HIV-infected patients opens new avenues in cardiovascular disease prevention within this demographic. Physicians may find the detailed insights on risk reduction and side effects beneficial in tailoring personalized care strategies.
Allergy & Immunology July 31st 2023
Pharmacy Practice News
The application of NIOSH Hazardous Drug Assessment principles to home healthcare is a critical development in ensuring safety. As home delivery of treatments like chemotherapy grows, understanding and implementing these principles become vital for healthcare professionals, patients, and their families. Explore how these principles are being adapted to protect all involved in this complex process.
Specialty Pharmacy Continuum
The recent study exploring the Mark Cuban Cost Plus Drug Company’s potential impact on Medicare’s oncology drug spending uncovers significant savings opportunities. Physicians may find interest in this model’s potential to improve access to essential cancer medications through reduced costs, emphasizing a call to examine current overpayment within the Medicare system.